CDEX Files Apparatus Patent Application for Portable, Hand-held Methamphetamine and Illicit Drug Detector
Company Prepares to Enter Homeland Security Market
ROCKVILLE, MD.–June 30, 2006– CDEX, Inc. (OTCBB: CEXI) announced today that it has filed an apparatus patent application for its Portable, Hand-held methamphetamine and Illicit Drug Detector in preparation for its entry into the Homeland Security market. The apparatus is capable of detecting trace amounts of methamphetamine, other illicit drugs, and other chemical substances. The apparatus incorporates CDEX core technology and will provide first responders (i.e., law enforcement, fire fighters, and HAZMAT teams) with a cost effective, real time method of conducting non-contact, non-destructive, field tests of suspicious substances.
Detection is accomplished by scanning a spectral beam across a surface to detect the presence of trace amounts of contamination left behind by methamphetamine, other illicit drugs, or other chemical substances. The device has the look and feel of a traffic radar gun, is battery operated, is capable of wired or wireless up/down loading of data, time and date stamps of all tests, and stores all test results for later retrieval.
“The development, protection, and practice of our intellectual property are vital to value creation for the company,” said Jim Griffin, President and CEO of CDEX. “The innovative application of our intellectual property to life-safety products such as the Portable, Hand-held Methamphetamine and Illicit Drug Detector Illicit is a key success factor in meeting market demand and executing our growth strategy.”
CDEX core technology is highly scalable. The company is currently developing products that incorporate the same patent pending technology currently used in existing CDEX products for other market segments. All current CDEX products are based on applying the same underlying photoelectric technology for which the company has five additional patents pending. CDEX has also filed corresponding international applications for each of these patents.
About CDEX, Inc.
CDEX Inc. (OTC Bulletin Board: CEXI - News), the manufacturer of the ValiMed System, is a technology development company focused on producing equipment that uses using chemical detection and validation technologies. CDEX technology is focused currently on two distinct areas: (i) identification of substances of concern (e.g., explosives and illegal drugs); and (ii) validation of substances for anti-counterfeiting, brand protection and quality assurance. CDEX is headquartered in Rockville, Maryland, with a primary research and development laboratory in Tucson, Arizona. For more information, visit www.cdex-inc.com and www.valimed.com.
|
